Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NovaBay Pharmaceuticals (NBY) Return on Invested Capital (2016 - 2021)

Historic Return on Invested Capital for NovaBay Pharmaceuticals (NBY) over the last 12 years, with Q3 2021 value amounting to 0.72%.

  • NovaBay Pharmaceuticals' Return on Invested Capital rose 1800.0% to 0.72% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.72%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.87% for FY2020, which is 16900.0% up from last year.
  • Latest data reveals that NovaBay Pharmaceuticals reported Return on Invested Capital of 0.72% as of Q3 2021, which was up 1800.0% from 0.65% recorded in Q2 2021.
  • In the past 5 years, NovaBay Pharmaceuticals' Return on Invested Capital ranged from a high of 0.49% in Q4 2020 and a low of 6.54% during Q2 2020
  • For the 5-year period, NovaBay Pharmaceuticals' Return on Invested Capital averaged around 2.31%, with its median value being 1.76% (2017).
  • In the last 5 years, NovaBay Pharmaceuticals' Return on Invested Capital tumbled by -63400bps in 2017 and then soared by 58900bps in 2021.
  • Over the past 5 years, NovaBay Pharmaceuticals' Return on Invested Capital (Quarter) stood at 3.3% in 2017, then surged by 57bps to 1.43% in 2018, then plummeted by -83bps to 2.61% in 2019, then soared by 81bps to 0.49% in 2020, then tumbled by -47bps to 0.72% in 2021.
  • Its Return on Invested Capital stands at 0.72% for Q3 2021, versus 0.65% for Q2 2021 and 0.55% for Q1 2021.